01—Abstract
Summary
Summary of the 8-K filed October 22, 2025. Cited figures are marked; the original filing is the authoritative source.
Citigroup Inc. (NYSE: C) filed this Form 8-K on October 22, 2025 under Item 9.01 (Financial Statements and Exhibits).
The filing is administrative in nature: it attaches an legal opinion from Karen Wang, Esq. (Exhibit 5.01), a schedule of Citigroup securities registered under Section 12(b) of the Exchange Act as of the filing date (Exhibit 99.01), and the Inline XBRL cover page (Exhibit 104). It does not report earnings, operating results, acquisitions, management changes, or any other material business event.
Exhibit 99.01 lists the securities currently registered on the New York Stock Exchange. These include Citigroup's common stock (ticker C), the 7.625%a Trust Preferred Securities of Citigroup Capital III (C/36Y), the 7.875% Fixed/Floating Rate TruPS of Citigroup Capital XIII (C N), and several Series N Floating Rate Medium-Term Senior Notes issued by Citigroup Global Markets Holdings Inc. (CGMHI) and guaranteed by Citigroup. The notes mature between September 2026 and March 2029.
The registration of these instruments is typically associated with a new issuance, a shelf update, or a periodic refresh of the registered securities list. For investors, the practical takeaway is that this filing does not change the company's financial position or outlook.
Its value lies in confirming the listed securities and the legal opinion supporting new registrations, which may point to ongoing debt issuance under Citigroup's medium-term note program. Investors seeking performance information should consult the company's quarterly 10-Q and earnings releases.
02—Key points
Key Highlights
- Filing type is administrative: Item 9.01 only, with no reported financial results or material business events
- Exhibit 5.01 is a legal opinion from Karen Wang, Esq., which typically supports the registration of new securities
- Exhibit 99.01 confirms Citigroup common stock (ticker C) and several trust preferred and debt securities are registered on the NYSE
- Listed trust preferred securities include the 7.625% TRUPs of Citigroup Capital III (C/36Y) and the 7.875% FXD/FRN TruPS of Citigroup Capital XIII (C N)
- Multiple Series N Floating Rate Medium-Term Notes issued by CGMHI, maturing from September 2026 to March 2029, are registered with Citigroup's guaranty
- Inline XBRL cover page (Exhibit 104) is included for machine-readable disclosure compliance
- No change to Citigroup's financial condition, guidance, or capital position is indicated in this filing
03—Questions
Frequently Asked Questions
Does this 8-K report Citigroup's quarterly earnings or financial results?
No. The filing covers only Item 9.01 (Financial Statements and Exhibits). It includes a legal opinion, a list of registered securities, and an XBRL cover page. Earnings and operating results are reported in separate earnings releases and periodic filings such as the 10-Q.
What do the Series N Floating Rate Notes listed here represent?
These are medium-term senior notes issued by Citigroup Global Markets Holdings Inc. (CGMHI), a wholly owned subsidiary, with Citigroup Inc. providing a guaranty. They have floating rates and maturities from September 2026 through March 2029. Their listing on the NYSE makes them publicly tradable securities.
Why would Citigroup file an 8-K with a legal opinion and a securities list?
Companies file these exhibits when registering securities, such as when issuing new notes or updating a shelf registration. The legal opinion confirms the securities are validly issued and the guaranty is enforceable. The securities list identifies which instruments are registered on the exchange as of the filing date.
Does this filing signal a change in Citigroup's capital structure?
Not directly. The filing does not announce a new offering amount, pricing, or a change to existing securities. It only documents which securities are registered. Investors should review any related prospectus supplements for details on new issuance size, terms, and pricing.
04—Continue